Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N W Preston

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Hygiene|April 1, 1976
Mouse or man? Which are pertussis vaccines to protect?N W Preston, T N Stanbridge
Lancet (London, England)|October 5, 1985
Whooping cough in West GermanyJ E Hoppe, N W Preston
The Journal of Hygiene|December 1, 1975
Type-specific action of vibriocidal antibody on Vibrio choleraeA H Pykett, N W Preston
Expert Opinion on Pharmacotherapy|October 5, 2001
Current pharmacotherapy of pertussisJ R Kerr, N W Preston
Lancet (London, England)|March 16, 1996
Components of acellular pertussis vaccinesN W Preston, R C Matthews
Lancet (London, England)|February 18, 1995
Immunological and bacteriological distinction between parapertussis and pertussisN W Preston, R C Matthews
Journal of Medical Microbiology|August 1, 1984
Association between Bordetella pertussis agglutinogen 2 and fimbriaeE J Carter, N W Preston
Lancet (London, England)|January 11, 1997
Toxoid vaccine for pertussisN W Preston, R C Matthews
Lancet (London, England)|June 23, 1998
Acellular pertussis vaccines: progress but déjà vuN W Preston, R C Matthews
British Medical Journal|August 19, 1972
Efficacy of pertussis vaccines: a brighter horizonN W Preston, T N Stanbridge
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Hygiene|April 1, 1976
Mouse or man? Which are pertussis vaccines to protect?N W Preston, T N Stanbridge
Lancet (London, England)|October 5, 1985
Whooping cough in West GermanyJ E Hoppe, N W Preston
The Journal of Hygiene|December 1, 1975
Type-specific action of vibriocidal antibody on Vibrio choleraeA H Pykett, N W Preston
Expert Opinion on Pharmacotherapy|October 5, 2001
Current pharmacotherapy of pertussisJ R Kerr, N W Preston
Lancet (London, England)|March 16, 1996
Components of acellular pertussis vaccinesN W Preston, R C Matthews
Lancet (London, England)|February 18, 1995
Immunological and bacteriological distinction between parapertussis and pertussisN W Preston, R C Matthews
Journal of Medical Microbiology|August 1, 1984
Association between Bordetella pertussis agglutinogen 2 and fimbriaeE J Carter, N W Preston
Lancet (London, England)|January 11, 1997
Toxoid vaccine for pertussisN W Preston, R C Matthews
Lancet (London, England)|June 23, 1998
Acellular pertussis vaccines: progress but déjà vuN W Preston, R C Matthews
British Medical Journal|August 19, 1972
Efficacy of pertussis vaccines: a brighter horizonN W Preston, T N Stanbridge
Pageof 8